###begin article-title 0
###xml 71 78 <span type="species:ncbi:9606">patient</span>
Golgi function and dysfunction in the first COG4-deficient CDG type II patient
###end article-title 0
###begin p 1
The authors wish it to be known that, in their opinion, the first two and last two authors should be regarded as joint First/Last Authors.
###end p 1
###begin p 2
###xml 318 325 <span type="species:ncbi:9606">patient</span>
###xml 862 870 <span type="species:ncbi:9606">patients</span>
###xml 991 999 <span type="species:ncbi:9606">patients</span>
The conserved oligomeric Golgi (COG) complex is a hetero-octameric complex essential for normal glycosylation and intra-Golgi transport. An increasing number of congenital disorder of glycosylation type II (CDG-II) mutations are found in COG subunits indicating its importance in glycosylation. We report a new CDG-II patient harbouring a p.R729W missense mutation in COG4 combined with a submicroscopical deletion. The resulting downregulation of COG4 expression additionally affects expression or stability of other lobe A subunits. Despite this, full complex formation was maintained albeit to a lower extent as shown by glycerol gradient centrifugation. Moreover, our data indicate that subunits are present in a cytosolic pool and full complex formation assists tethering preceding membrane fusion. By extending this study to four other known COG-deficient patients, we now present the first comparative analysis on defects in transport, glycosylation and Golgi ultrastructure in these patients. The observed structural and biochemical abnormalities correlate with the severity of the mutation, with the COG4 mutant being the mildest. All together our results indicate that intact COG complexes are required to maintain Golgi dynamics and its associated functions. According to the current CDG nomenclature, this newly identified deficiency is designated CDG-IIj.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C1">1</xref>
###xml 382 383 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 503 504 503 504 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 507 508 507 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sub>
###xml 514 515 514 515 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 606 607 606 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C2">2</xref>
###xml 676 677 676 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 759 760 759 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 844 845 844 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 851 852 851 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1213 1216 1213 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1220 1225 1220 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1236 1237 1236 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C3">3</xref>
###xml 1359 1362 1359 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1366 1371 1366 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1661 1662 1661 1662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C4">4</xref>
###xml 1663 1664 1663 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C7">7</xref>
###xml 1756 1761 1756 1761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1839 1840 1839 1840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C8">8</xref>
###xml 1841 1842 1841 1842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C9">9</xref>
###xml 2110 2112 2110 2112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C10">10</xref>
###xml 2795 2800 <span type="species:ncbi:4932">yeast</span>
The Golgi apparatus is an important relay station in the secretory pathway as it plays a pivotal role in targeting proteins and lipids to distinct post-Golgi compartments (1). During transit through the Golgi apparatus, most of the newly synthesized secretory and membrane-bound proteins undergo major modifications, mainly involving different types of glycosylation. One of these, N-glycosylation, is a complex series of reactions, starting in the endoplasmic reticulum (ER) with the formation of a Glc3Man9GlcNAc2-PP-Dolichol structure, which is subsequently transferred onto newly synthesized proteins (2). Upon exit from the ER and arrival in the Golgi, these unprocessed N-glycan chains are trimmed and modified to give rise to distinct types of complex N-glycan structures. Most of the other types of glycosylation, like the formation of O- and C-glycans, are restricted to either the ER or the Golgi apparatus. To maintain the directional flow of transport, essential for these modifications, the Golgi apparatus is built out of stacked cisternae, laterally interlinked via fenestrated continuities. The differential distribution of proteins and enzymes over these stacks provides the Golgi complex with a cis-to-trans polarity (3). A tightly regulated organization of transport is required in order to mediate cargo transit as well as to maintain the cis-to-trans organization. The exact mechanism of this transit is still not clarified, though it will most likely be a combination of the vesicular transport model, which implicates fixed cisternae with vesicles transporting cargo forward and recycling escaped proteins to earlier cisternae or the ER (4-7) and the cisternal maturation model. In the latter model, the cisternae mature towards the trans-side while vesicles constantly recycle enzymes back to earlier compartments (8,9). More recently a two-phase membrane system was proposed in which small soluble cargo distributes equally across the stack and membrane proteins prefer certain cisternae only based on, for instance, the local lipid composition and length of the transmembrane domain (10). Irrespective of the different models and its specificity and directionality, intra-Golgi transport requires a large number of proteins and protein complexes. These include COPI-coat proteins and associated small GTPases, like ARF1 mediating budding/fission, as well as 'Soluble NSF attachment protein receptor' family members that govern vesicle fusion. The targeting specificity is often organized through the concerted action of GTP-bound Rab proteins with so-called tethering complexes, which are soluble multimeric complexes, coupling incoming organelles with the fusion site. One example is the exocyst complex that acts as a tethering complex at the cell surface of budding yeast and in mammalian cells. The main tethering complexes in the early secretory pathway are the 'Transport Protein Particle' (TRAPP) I and II complexes which couple ER-derived vesicles to the ER-Golgi intermediate compartment and the conserved oligomeric Golgi (COG) complex which appears to function in intra-Golgi and/or Golgi-to-ER trafficking.
###end p 4
###begin p 5
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C11">11</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C12">12</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C13">13</xref>
###xml 929 931 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C12">12</xref>
###xml 932 934 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C14">14</xref>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C19">19</xref>
###xml 999 1001 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C20">20</xref>
###xml 1002 1004 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C21">21</xref>
###xml 1388 1389 1388 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 63 68 <span type="species:ncbi:4932">yeast</span>
###xml 412 426 <span type="species:ncbi:10029">CHO cell lines</span>
The COG complex is an octameric hetero-oligomer conserved from yeast to mammals and presents as a bi-lobed structure bridged through the COG1-COG8 interaction (11,12). Deficiencies in single subunits lead to impaired functioning of the COG complexes, concomitant defects in Golgi morphology (13) and affecting the correct functioning of the cell or entire organism. For instance, a deficiency of COG1 or COG2 in CHO cell lines showed a defective retrograde Golgi-to-ER transport, a subsequent disturbance of the Golgi morphology and a destabilization of several proteins, including glycosylation enzymes, thus causing glycosylation abnormalities. The importance of COG function in intra-Golgi transport and its secondary implications on glycosylation are furthermore underscored by the discovery of mutations in the genes encoding the COG1, COG7 and COG8 subunits that were linked to congenital disorders of glycosylation (CDG) (12,14-19). CDG is a rare, recessive disorder first described in 1980 (20,21). Since then, 22 subtypes have been described, which can be divided into two different groups: CDG type I and type II. CDG type I (CDG-I) is caused by defects in enzymes governing the synthesis and transfer of the oligosaccharide in the ER. On the other hand, defects leading to CDG-II have been shown to belong to different classes: enzymes responsible for the modifications of the N-glycan chain in the Golgi apparatus, sugar transporters in the Golgi membrane and complexes essential for intra-Golgi and retrograde Golgi-to-ER transport such as the COG complex.
###end p 5
###begin p 6
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COG4</italic>
###xml 361 364 361 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COG</italic>
###xml 1166 1169 1166 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COG</italic>
###xml 19 26 <span type="species:ncbi:9606">patient</span>
###xml 164 171 <span type="species:ncbi:9606">patient</span>
###xml 293 301 <span type="species:ncbi:9606">patients</span>
###xml 990 998 <span type="species:ncbi:9606">patients</span>
Here we describe a patient harbouring a heterozygous point mutation in the COG4 gene combined with a deletion on the maternal allele. Experiments performed on this patient's fibroblasts yielded similar defects albeit less severe as found in the cells of the previously described COG-deficient patients. Moreover, we present an updated overview of the different COG mutations identified thus far in which we attempt to correlate for the first time the respective clinical phenotypes with the severity in glycosylation and trafficking defects as well as with the Golgi integrity using transmission electron microscopy (TEM). Our analysis underscores the high importance of an intact COG complex in both intra-Golgi trafficking and the maintenance of the normal morphology of the Golgi apparatus. Furthermore, we provide novel insights in the steady-state localization of both full and partial complexes with implications on the action mechanism of the complex. With this study, the number of patients harbouring mutations in individual COG genes rises to ten, which is about one-third of the total number of CDG-II cases in which a mutation has been identified making COG mutations one of the most frequent causes of CDG-II. Furthermore, given the insights that the different individual studies have generated on COG complex formation and functioning, we are now at a point where a comparison of all mutant subunits along different criteria reveals more specific or even as yet unknown functions of not only the full complex, but also of different subunits and subcomplexes.
###end p 6
###begin title 7
RESULTS
###end title 7
###begin title 8
Genetic and molecular analysis of COG4
###end title 8
###begin p 9
###xml 267 270 267 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COG</italic>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COG4</italic>
###xml 464 465 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F1">1</xref>
###xml 666 667 666 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F1">1</xref>
###xml 42 50 <span type="species:ncbi:9606">patients</span>
###xml 308 316 <span type="species:ncbi:9606">patients</span>
###xml 340 347 <span type="species:ncbi:9606">patient</span>
The identification of several CDG type II patients harbouring mutations in individual subunits of the octameric COG complex fostered a strong interest in the functional role this Golgi tethering complex plays in the glycosylation process. By direct sequencing of the COG genes in a cohort of unsolved CDG-II patients, we identified a novel patient carrying a seemingly homozygous C>T point mutation at position 2185 in the genomic DNA encoding the COG4 gene (Fig. 1A). The mutation was not found after sequencing of over 100 alleles of a randomly chosen European control population. At the protein level, this mutation converts a highly conserved arginine 729 (Fig. 1B) into a tryptophan residue (p.R729W).
###end p 9
###begin p 10
###xml 71 72 71 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 211 218 211 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 1027 1028 1011 1012 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1131 1132 1115 1116 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1382 1383 1366 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1422 1423 1406 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1496 1497 1478 1479 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1693 1694 1675 1676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1723 1724 1705 1706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1798 1799 1780 1781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1808 1809 1788 1789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1819 1820 1797 1798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 61 68 <span type="species:ncbi:9606">patient</span>
###xml 138 145 <span type="species:ncbi:9606">patient</span>
###xml 451 458 <span type="species:ncbi:9606">patient</span>
###xml 605 612 <span type="species:ncbi:9606">patient</span>
###xml 867 874 <span type="species:ncbi:9606">patient</span>
###xml 1165 1172 <span type="species:ncbi:9606">patient</span>
###xml 1486 1493 <span type="species:ncbi:9606">patient</span>
###xml 1527 1534 <span type="species:ncbi:9606">patient</span>
Genetic and molecular characterization of the described COG4 patient. (A) Sequencing revealed a heterozygous C>T missense mutation in the patient and the absence of this mutation in the mother. The fluorescence in situ hybridization (FISH) image shows the deletion of fosmid G24P85580E2 (red) on the maternal allele, whereas the control subtelomeric 16q fosmid (green) shows a normal signal. A schematic representation of the mutations present in the patient is given, the green and red asterisk on the maternal allele indicate, respectively, the last heterozygous SNP and the first hemizygous SNP in the patient, the black asterisk on the paternal allele indicates the position of the missense mutation, green regions indicate genes (> em leader>: sense/< em leader<: antisense/bars indicate the location of each gene) and intergenic regions that are present in the patient, the white and grey regions on the maternal allele indicate, respectively, the known deleted region and the region containing the proximal breakpoint. (B) Alignment of the COG4 sequence of different species shows an absolute conservation of this residue. (C) Lysates of a control, the COG4 patient and both parents were loaded on SDS-PAGE gel to analyze the COG4 levels. Quantifications represent the mean values of three independent loadings of independent samples. Error bars represent the SEM, a Student t-test resulted in a highly significant P-value (</=0.001-indicated as ****) when comparing control and patient. (D) Western blot of control and patient for all COG subunits. Quantifications represent the mean values of three independent loadings of independent samples. Error bars represent the SEM, a Student t-test was used to obtain the P-values indicated in the graph as */***/****, representing, respectively, P </= 0.1/P </= 0.01/P </= 0.001.
###end p 10
###begin p 11
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F1">1</xref>
###xml 160 167 160 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COG4</italic>
###xml 567 574 567 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 724 725 724 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F1">1</xref>
###xml 819 823 819 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COG4</italic>
###xml 1289 1290 1289 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F1">1</xref>
###xml 1356 1359 1356 1359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FUK</italic>
###xml 1387 1391 1387 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COG4</italic>
###xml 1420 1421 1420 1421 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 1522 1524 1522 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C22">22</xref>
###xml 1579 1580 1579 1580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1697 1701 1697 1701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COG4</italic>
###xml 365 372 <span type="species:ncbi:9606">patient</span>
###xml 1596 1603 <span type="species:ncbi:9606">patient</span>
Sequencing of the parental DNA confirmed the father as being heterozygous for this mutation, whereas the mother only presented the normal sequence (Fig. 1A). A de novo mutation on the maternal allele was excluded by the identification of two single nucleotide polymorphisms (SNPs), in exon 5 and exon 18, which also showed an abnormal inheritance pattern, i.e. the patient having no obvious maternal contribution for the COG4 allele (data not shown). A uniparental paternal isodisomy of (a part of) chromosome 16 could also be excluded (data not shown). Fluorescence in situ hybridization using fosmid clones demonstrated a deletion of clone G25P85580E2, pointing to a submicroscopical deletion on the maternal allele (Fig. 1A). On the basis of the results of other fosmids, we inferred that the first two exons of the COG4 gene are present, whereas the 3' breakpoint should be located in a 5 kb region between intron 2 and the fifth exon. The proximal breakpoint has not been identified but, based on SNP mapping, we delineated a 47 kb region containing the deletion breakpoint. The closest SNP with a normal biparental inheritance pattern was rs3852695, located 97 kb upstream of the COG4 start codon, whereas rs7192865 was the first hemizygous SNP, located 50 kb upstream of COG4 (Fig. 1A). The only other gene (largely) included in the deletion is the FUK gene, just upstream of the COG4 gene. This gene encodes the l-fucose kinase, necessary for the reutilization of fucose after the degradation of oligosaccharides (22). Since no decreased fucosylation was observed in the N-glycans of our patient, we conclude that the (partial) monosomy of this gene is not pathogenic. In our opinion, the COG4 deletion and point mutation are the sole responsible for the identified clinical and cellular abnormalities. This mutation defines a new subtype of CDG-II, which we named the COG4 defect (COG4/CDG) or CDG-IIj.
###end p 11
###begin p 12
###xml 4 11 <span type="species:ncbi:9606">patient</span>
###xml 40 45 <span type="species:ncbi:9606">child</span>
###xml 115 118 <span type="species:ncbi:9606">boy</span>
###xml 173 178 <span type="species:ncbi:9606">child</span>
###xml 1055 1060 <span type="species:ncbi:9606">child</span>
The patient described here is the first child of healthy, unrelated Portuguese parents. Until the fourth month the boy had a normal development, but after a vaccination the child started fever and progressive irritability. He was hospitalized due to complex seizures, which were eventually suppressed by phenobarbital. Some dysmorphic features were noted, like a peculiar face (down sloping frontal area and thick hair) combined with axial hyponia, slight peripheral hypertonia and hyperreflexia. Blood tests revealed increased serum transaminases, alkaline phosphatases and LDH cholesterol levels, while the platelet counts were down. Because CDG was suspected, isoelectric focusing of serum transferrin was performed and showed a type 2 pattern (). Brain MRI, ophtamological and cardiological investigations were normal, as well as serum immunoglobulins and hormones, but a decrease of coagulation factors was noted. Since the age of 12 months he was regularly admitted to the hospital due to recurrent respiratory infections. At the age of 3 years the child presented with microcephaly, bilateral cerebral atrophy of the frontotemporal regions, a mild degree of ataxia, brisk, uncoordinated movements, absence of speech and moderate psychomotor delay.
###end p 12
###begin title 13
COG subcomplexes reside in the cytosol
###end title 13
###begin p 14
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COG4</italic>
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F1">1</xref>
###xml 460 464 460 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COG4</italic>
###xml 742 746 742 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COG4</italic>
###xml 753 754 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F1">1</xref>
###xml 132 139 <span type="species:ncbi:9606">patient</span>
The combination of both the mutant COG4 and the deleted allele has a dramatic effect on COG4 protein levels that drop to 20% in the patient's fibroblasts compared with control (Fig. 1C). Interestingly, the low COG4 levels also affected the other subunits of lobe A by 50% for COG3, 40% for COG2 and 25% for COG1. In lobe B only a 40% decrease was observed for COG5, whereas all others remained indistinguishable from the control. We can thus conclude that the COG4 mutation mainly renders lobe A subunits instable without affecting dramatically (except for COG5) lobe B subunits. Western blot analysis for COG4 on extracts derived from maternal and paternal fibroblasts displayed normal protein levels despite the mother being hemizygous for COG4 (Fig. 1D). Hence, the second, normal allele likely compensates for the deletion, explaining the absence of any phenotypical abnormalities in the mother. With respect to the father, the COG4 levels are slightly affected, suggesting that the mutant COG4 is more prone to degradation.
###end p 14
###begin p 15
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F2">2</xref>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C12">12</xref>
###xml 1188 1189 1188 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F2">2</xref>
###xml 2098 2103 2086 2091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 2106 2108 2094 2096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C12">12</xref>
###xml 2514 2515 2502 2503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F2">2</xref>
###xml 2908 2910 2896 2898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C13">13</xref>
###xml 2911 2913 2899 2901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C23">23</xref>
###xml 2914 2916 2902 2904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C27">27</xref>
###xml 154 161 <span type="species:ncbi:9606">patient</span>
###xml 615 622 <span type="species:ncbi:9606">patient</span>
###xml 2074 2081 <span type="species:ncbi:9606">patient</span>
###xml 2156 2163 <span type="species:ncbi:9606">patient</span>
###xml 2297 2304 <span type="species:ncbi:9606">patient</span>
###xml 2488 2495 <span type="species:ncbi:9606">patient</span>
###xml 2695 2702 <span type="species:ncbi:9606">patient</span>
###xml 2807 2812 <span type="species:ncbi:4932">yeast</span>
###xml 3021 3026 <span type="species:ncbi:9606">human</span>
We next explored the effect of decreased mutant COG4 levels on the integrity of the full COG complex. Cytosolic and membrane extracts of control and COG4 patient fibroblasts were fractionated by glycerol gradient centrifugation and analyzed by western blotting. No apparent differences in the size distribution of the COG complexes were noticed when compared with control cytosolic and membrane fractions (Fig. 2A). This demonstrates that, despite the mutant COG4 and lowered levels of several individual COG subunits, complexes can still be formed. This contrasts with the observations made for the COG8-deficient patient (12). On the other hand, we observed clear differences between cytosolic and membrane extracts with COG complexes distributing in much lighter fractions of the cytosolic gradients and in a more restricted manner (fractions 2-6). In comparison, the 669 kDa marker thyroglobulin was recovered mainly in fraction 6. In the case of membrane extracts, COG subunits were more broadly distributed and found in higher fractions as well. Moreover, when comparing the absolute amounts of cytosolic and membrane-associated COG subunits, most is recovered in the cytosol (Fig. 2B). Taken together, these results suggest that the full complex, with an estimated weight of approximately800 kDa, is mainly present on the membrane. The broad distribution of the COG proteins in the membrane gradients indicates that both the full complex and subcomplexes coexist in the membrane. The cytosol contains the major pool of COG proteins, but mainly in the form of subcomplexes, probably corresponding to lobe A and B. In the light of this, it is tempting to suggest that subcomplexes present on the vesicle and target membrane recombine to full COG complexes upon tethering of the incoming vesicle with the Golgi membrane. Alternatively, we cannot exclude that full complexes are assembled in the cytosol and then immediately recruited to the membrane, initiating vesicle tethering (see Discussion). These results are in agreement with previous data on the COG8-deficient patient where Foulquier et al. (12) showed that the cytosolic COG proteins in the patient were present in lighter fractions when compared with the control. When extending this analysis to the membrane fractions of the COG8 patient's fibroblasts in this study, we also noticed a more restricted distribution towards lighter fractions in accordance with the lack of full COG complex assembly on the membrane in COG8 patient fibroblasts (Fig. 2C). Upon comparison of the percentage of the COG3, -4, -7 and -8 proteins in the different fractions, the complexes in the cytosol appear definitely smaller, whereby only the COG8 patient showed a defect in full complex formation (). These data seem to be in disagreement with the reports on yeast and CHO cells, reporting the presence of the majority of the COG proteins in the full complex (13,23-27). However, we feel caution is needed when extrapolating experiments from different organisms to primary human fibroblasts, since differences in the mechanism of the formation of the full complex cannot be excluded.
###end p 15
###begin p 16
###xml 74 75 74 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 174 175 174 175 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 530 531 530 531 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 760 761 760 761 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 190 197 <span type="species:ncbi:9606">patient</span>
###xml 619 626 <span type="species:ncbi:9606">patient</span>
###xml 742 749 <span type="species:ncbi:9606">patient</span>
###xml 862 869 <span type="species:ncbi:9606">patient</span>
The COG4 mutation does not abrogate normal assembly of the full complex. (A) Glycerol gradient centrifugation was performed on cytosolic and membrane fractions of a control (C) and the COG4 patient (P4), all 12 fractions obtained were loaded onto SDS-PAGE gels and the distribution of COG3, -4, -7 and -8 was analyzed using western blot, asterisks indicate the migration of the 669 kDa marker thyroglobulin. Exposure times differ between cytosolic and membrane fractions, due to the mainly cytosolic localization of the complex. (B) Cytosol and membrane fractions were obtained from the cells of a control and the COG4 patient. Quantifications after western blot shows that there is no difference between the COG4 distribution in control and patient's cells. (C) Glycerol gradient centrifugation was performed on membrane fractions of a control (C) and the COG8 patient (P8), all 12 fractions obtained were loaded onto SDS-PAGE gels and the distribution of the COG1, -3 and -8 proteins was analyzed using western blot, asterisks indicate the migration of the 669 kDa marker thyroglobulin. Exposure times differ between cytosolic and membrane fractions, due to the mainly cytosolic localization of the complex.
###end p 16
###begin p 17
###xml 147 150 147 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 208 215 <span type="species:ncbi:9606">patient</span>
At the endogenous level, all COG subunits show a preferential localization to the Golgi region as demonstrated by the colocalization with GM130, a cis-Golgi marker. Similar observations were made in the COG4 patient's fibroblasts where all COG proteins localized to the Golgi (), in spite of the very low levels of mutant COG4 (and other subunits) in these cells. The absence of a significantly different localization could be due to the large cytosolic pool from which subcomplexes can be recruited. These and previous findings suggest that the mutation in COG4 generates a more subtle effect in the COG complex function, for instance by affecting recruitment of other regulatory components in membrane tethering.
###end p 17
###begin title 18
The degree of Golgi dysfunction grossly correlates with the clinical phenotype
###end title 18
###begin p 19
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C12">12</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C15">15</xref>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C17">17</xref>
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP262TB1">1</xref>
###xml 22 29 <span type="species:ncbi:9606">patient</span>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
###xml 212 219 <span type="species:ncbi:9606">patient</span>
###xml 278 285 <span type="species:ncbi:9606">patient</span>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
Next we compared this patient with three patients harbouring mutations in COG1, COG7 or COG8 (12,15,17) on multiple parameters. With respect to the clinical phenotypes (Table 1 and ), it is evident that the COG7 patient is most affected. Also the clinical phenotype of the COG8 patient is quite severe, whereas the COG4 and mainly the COG1 patients present with milder problems. The question now rises whether this correlates with the defects observed at the cellular level.
###end p 19
###begin p 20
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Comparison of the different patients for all investigated defects
###end p 20
###begin p 21
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C13">13</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C28">28</xref>
###xml 364 365 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 644 645 644 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F3">3</xref>
###xml 791 792 791 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1131 1133 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C29">29</xref>
###xml 1403 1404 1391 1392 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1410 1411 1398 1399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1472 1473 1460 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1550 1551 1538 1539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 2148 2150 2118 2120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C30">30</xref>
###xml 30 38 <span type="species:ncbi:9606">patients</span>
###xml 420 428 <span type="species:ncbi:9606">patients</span>
###xml 587 595 <span type="species:ncbi:9606">patients</span>
###xml 691 699 <span type="species:ncbi:9606">patients</span>
###xml 821 829 <span type="species:ncbi:9606">patients</span>
###xml 989 996 <span type="species:ncbi:9606">patient</span>
###xml 1390 1398 <span type="species:ncbi:9606">patients</span>
###xml 1659 1662 <span type="species:ncbi:9606">Man</span>
The initial classification of patients with mutations in COG subunits as CDG-II already identifies them with defects in the maturation of the N- (and O-) glycan chains and implicates a crucial role of the COG complex in the normal glycosylation reaction as observed also in COG subunit deficient cells (13,28). Indeed, a comparative mass-spectrometric analysis of N-glycans on serum samples of four COG-deficient CDG-II patients reveals multiple abnormal oligosaccharide structures and changes in the relative amounts of individual oligosaccharides. A common observation between all COG patients is the decrease in or lack of sialylation (Fig. 3A-B). With respect to this, the COG1 and COG4 patients are most, respectively least, severely affected. When comparing the galactosylation of the N-glycans, both COG1 and COG7 patients were most affected with agalactosylated glycan structures in, respectively, 11 and 40% of the glycans. This result was striking since in the described CDG-IId patient this defect is not observed, despite a proven 95% reduction in the beta-1,4-galactosyltransferase-1 (beta-1,4-GalT1) enzyme activity (29). One explanation could be that the altered recycling of the beta-1,4-GalT1 enzyme, due to COG deficiencies, has a more severe effect on the formation of the correct glycan structure than a reduced beta-1,4-GalT1 expression. Furthermore, only in these two patients, Man5GlcNAc2 structures were abundantly detected. The absence of a third N-acetylglucosamine (GlcNAc) monosaccharide is most likely due to a decreased N-acetylglucosaminyl transferase 1 (GlcNAcT1) activity rather than a destabilization of ManII since mannose (Man) Ndegrees6 and Ndegrees8 can only be cleaved after a GlcNAc residue is added onto the free mannose Ndegrees2 by GlcNAcT1. Both the GlcNAcT1 and ManII enzymes reside in the same cisternae and are therefore tightly associated with one another, in order to ensure their sequential activity. Our observation is in line with earlier data on the depletion of either lobe A or lobe B of the COG complex, which severely affects localization of medial-Golgi enzymes such as GlcNAcT1 and ManII (30) and which in turn suggests a Golgi disorganization.
###end p 21
###begin p 22
###xml 21 22 21 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 90 91 90 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 198 199 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 263 264 263 264 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 475 476 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
###xml 149 157 <span type="species:ncbi:9606">patients</span>
###xml 252 260 <span type="species:ncbi:9606">patients</span>
###xml 420 428 <span type="species:ncbi:9606">patients</span>
###xml 540 548 <span type="species:ncbi:9606">patients</span>
Presence of abnormal N-glycosylated proteins in the serum of the COG-deficient patients. (A) Mass spectrometry results of serum samples of all known patients and a control, show a deficiency in the N-glycosylation pathway in the Golgi apparatus in all patients. (B) Quantification of the results shown in (A), the control values are the mean of the results obtained from serum samples of three independent controls. All patients have a clear decrease in sialylation of their N-glycan chains (m/z 2431 and 2605), furthermore the COG1 and -7 patients also show a remarkable galactosylation (m/z 2040) and demannosylation (m/z 1580) deficiency.
###end p 22
###begin p 23
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C31">31</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C33">33</xref>
###xml 555 556 555 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F4">4</xref>
###xml 684 685 684 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F4">4</xref>
###xml 1332 1333 1328 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F4">4</xref>
###xml 66 74 <span type="species:ncbi:9606">patients</span>
###xml 355 362 <span type="species:ncbi:9606">patient</span>
###xml 749 756 <span type="species:ncbi:9606">patient</span>
###xml 1433 1440 <span type="species:ncbi:9606">patient</span>
Even though the glycosylation defect allowed us to classify these patients as CDG-II, it is likely not the primary defect. The aberrant glycosylation may result from the abnormal transport or distribution of glycosylation enzymes and possibly also nucleotide-sugar transporters. To test the integrity of the retrograde Golgi-to-ER trafficking, we treated patient cells for 6 min with Brefeldin A (BFA), a fungal metabolite that rapidly redistributes Golgi enzymes to the ER (31-33), and counted the number of cells which still showed Golgi remnants (Fig. 4B). While in the control virtually, no cells could be detected with Golgi remnants, as measured by ManII immunoreactivity (Fig. 4A), its BFA-induced redistribution was significantly delayed in patient cells, most dramatically in COG7 and COG1 mutant cells (respectively, 90% (SEM: +/- 2%) and 75% (+/- 2%) of cells with Golgi remnants). A significant but less severe retrograde transport delay was observed in the COG4 and COG8 fibroblasts. The difference between COG4 and COG8 cells persisted in shorter BFA treatments but caught up with longer treatments (data not shown). On the contrary, no differences were found after 90 min of BFA wash-out, this time point was chosen since shorter incubations resulted in only a partial restoration of the Golgi in control cells (Fig. 4A) These data indicate no delay in anterograde transport and Golgi restoration in the COG-deficient patient cells.
###end p 23
###begin p 24
###xml 59 60 59 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 486 487 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 516 517 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 588 589 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 599 600 597 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 613 614 609 610 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 23 31 <span type="species:ncbi:9606">patients</span>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
###xml 695 702 <span type="species:ncbi:9606">patient</span>
Cells of all known COG patients show trafficking defects. (A) Cells of all patients and four controls were treated with Brefeldin A for 6 or 60 min followed by wash-out of the drug. Cells were stained for GM130 and ManII, 300 cells were counted per cell line and based on the ManII staining each counted cell was scored for the presence or absence of Golgi (remnants), the results are averages of three independent experiments per cell line, the error bars represent the SEM, a Student t-test was used to obtain the P-values indicated in the graph as **/****, representing, respectively, P </= 0.05/P </= 0.001. (B) Representative confocal laser scanning microscopy (CLSM) images of control and patient cells obtained after staining for GM130 (green) and ManII (red). Both 60x and representative zoomed pictures are shown, scale bars represent 10 microm.
###end p 24
###begin p 25
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F5">5</xref>
###xml 959 960 957 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F5">5</xref>
###xml 1156 1157 1154 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F5">5</xref>
###xml 80 87 <span type="species:ncbi:9606">patient</span>
###xml 435 442 <span type="species:ncbi:9606">patient</span>
###xml 685 692 <span type="species:ncbi:9606">patient</span>
###xml 1080 1087 <span type="species:ncbi:9606">patient</span>
We next attempted to rescue the BFA-induced retrograde transport defect in COG4 patient cells by introducing wild-type COG4 using retroviral transduction. BFA-treatment of these transduced cells did not result in a normalized retrograde trafficking (Fig. 5A). Surprisingly, stable transduction of control cells with COG4 (thereby doubling expression levels) resulted in a retrograde trafficking defect, reminiscent of that observed in patient cells. This indicates that COG4 overexpression leads to a dominant-negative effect on trafficking making rescue experiments very difficult. Therefore, we down-regulated COG4 in HeLa cells to try and mimic the transport defect observed in the patient's cells, by transfection of these cells with a 'smart pool' of four different RNAi oligonucleotides. This yielded a reproducible and nearly complete downregulation of COG4 (3.2 +/- 3.5% remaining protein) when compared with untreated or mock-transfected cells (Fig. 5B). Subsequent BFA treatment showed a significant delay in ManII re-distribution underscoring that the mutations in the patient result in a trafficking delay and are likely to be pathogenic (Fig. 5B).
###end p 25
###begin p 26
###xml 89 90 89 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 511 512 511 512 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 986 987 986 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1034 1035 1034 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 92 99 <span type="species:ncbi:9606">Patient</span>
###xml 293 300 <span type="species:ncbi:9606">patient</span>
Effects of COG4 overexpression and downregulation on the retrograde trafficking defect. (A) Patient and control cells were transduced with COG4-containing viral particles, the resulting overexpression was analyzed on western blot and compared with COG4 levels present in untreated control and patient cells. After BFA treatment of all four cell lines the percentage of abnormal cells was counted, based on ManII staining, results are averages of three independent BFA treatments, error bars represent the SEM. (B) HeLa cells were transfected three times independently with a 'smart pool' of RNAi oligo's specific for the COG4 sequence (S). The extent of downregulation was assessed using western blot and compared with untreated cells (UT) and cells treated with a non-specific oligo (NS). The percentage of abnormal cells, counted after BFA treatment and ManII staining, is represented in the graph as an average of three different experiments. Error bars represent the SEM, a Student t-test was performed resulting in a significant P-value of 0.022, when compared with the untreated cells.
###end p 26
###begin title 27
Ultrastructural support for a role for the COG complex in maintaining Golgi integrity
###end title 27
###begin p 28
###xml 593 594 593 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F6">6</xref>
###xml 1332 1333 1332 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F6">6</xref>
###xml 227 235 <span type="species:ncbi:9606">patients</span>
###xml 417 424 <span type="species:ncbi:9606">patient</span>
###xml 739 746 <span type="species:ncbi:9606">patient</span>
###xml 1452 1459 <span type="species:ncbi:9606">patient</span>
###xml 1830 1837 <span type="species:ncbi:9606">patient</span>
Since Golgi integrity is maintained dynamically, we predicted that COG subunit mutations or deficiencies may alter Golgi morphology. Using confocal microscopy, we indeed noticed dilatation and fragmentation of the Golgi in all patients' cells (data not shown). However, since confocal microscopy does not give the resolution needed to observe the specific and subtle changes we decided to perform TEM analysis on all patient cells. The overall Golgi integrity was substantially to very severely disrupted in all investigated cell lines, although some distinct observations could be made (Fig. 6 and ). First, only in COG1 and, albeit to a lesser extent, in COG4 cells few typical Golgi cisternae could still be discerned. In COG7 and COG8 patient cells on the contrary, virtually no normally organized stacks were found. In these cells, individual Golgi stacks had an undulated appearance suggesting a decreased rigidity maybe caused by a weaker connection to the underlying cytoskeleton, although this remains to be investigated. Further, fragmented or vesiculated Golgi membranes were predominantly observed in the COG8-deficient cells and less frequent in COG4 and COG1 cells. Fragmentation was not clearly observed in the COG7 cells but instead the Golgi areas presented with many individual swollen cisternae (asterisk in Fig. 6). Such swollen cisternae were also frequently seen in COG8 cells. It should be noticed that at the EM level many COG7 patient cells appeared necrotic indicating that the observed ultrastructural defects in the surviving cells are an underestimation of the true phenotype. Again, a correlation can be found between the severity of the disease and the corresponding ultrastructural defects. Surprisingly, however, and in spite of having severe structural deficits in Golgi integrity and transport, patient cells still maintain a significant degree of complex glycosylation.
###end p 28
###begin p 29
###xml 740 745 740 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
###xml 175 182 <span type="species:ncbi:9606">patient</span>
###xml 271 279 <span type="species:ncbi:9606">patients</span>
###xml 335 343 <span type="species:ncbi:9606">patients</span>
###xml 574 581 <span type="species:ncbi:9606">patient</span>
###xml 672 680 <span type="species:ncbi:9606">patients</span>
Analysis of the Golgi morphology at the submicroscopical level. Cells of all patients and one control were subjected to electron microscopy. Both the COG1- and COG4-deficient patient cells still show some stacks with a normal morphology, in contrast to the COG7 and COG8 patients. The most striking finding mainly in the COG7 and COG8 patients was the undulated appearance of the stacked cisternae, as indicated by the arrowheads. Furthermore, several stacks have a fragmented and/or vesiculated appearance, indicated by arrows, a phenotype which is most severe in the COG8 patient. The asterisks indicate swollen cisternae which were present in a differing degree in all patients. The '>'points to clathrin-coated vesicles, indicating the trans-side of the Golgi apparatus.
###end p 29
###begin title 30
DISCUSSION
###end title 30
###begin title 31
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Clinical comparison of different COG-deficient CDG-II patients
###end title 31
###begin p 32
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C12">12</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C14">14</xref>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C19">19</xref>
###xml 589 590 589 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DDP262TB1">1</xref>
###xml 524 532 <span type="species:ncbi:9606">patients</span>
###xml 713 721 <span type="species:ncbi:9606">patients</span>
###xml 795 802 <span type="species:ncbi:9606">patient</span>
###xml 919 927 <span type="species:ncbi:9606">patients</span>
###xml 1025 1032 <span type="species:ncbi:9606">patient</span>
The present study identifies a novel mutation in the COG4 subunit of the COG complex (designated as CDG-IIj), which further expands the subgroup of CDG-II cases caused by mutations in the COG complex (12,14-19). Thus far, mutations have been detected in the COG1, COG7 and COG8 subunits and range from premature stop codons in the COG1 and COG8 to splice site mutations in the COG1 and COG7 subunits. Here, we describe a missense mutation combined with a microdeletion in COG4. The clinical and cellular phenotypes in these patients differ accordingly from mild to severe or lethal (Table 1 and ). Herein, the COG4 phenotype is one of the mildest in this subcategory of CDG-II. Most severe are the COG7-deficient patients displaying early post-natal lethality. The overall phenotype of the COG8 patient, presenting with neurological regression, cerebellar atrophy and hypotonia, is in between that of the COG7 and COG4 patients. While the COG1 mutation causes an early stop codon and hence a large C-terminal truncation, the patient suffers only from mild psychomotor retardation.
###end p 32
###begin title 33
Effects of the p.R729W COG4 mutation on complex formation and its function
###end title 33
###begin p 34
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C12">12</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C14">14</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C19">19</xref>
###xml 634 642 634 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C11">11</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C27">27</xref>
###xml 1028 1030 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C12">12</xref>
###xml 1031 1033 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C24">24</xref>
###xml 2428 2429 2428 2429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F7">7</xref>
###xml 2731 2733 2731 2733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C34">34</xref>
###xml 2792 2794 2792 2794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C34">34</xref>
###xml 3046 3048 3046 3048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C35">35</xref>
###xml 3055 3056 3055 3056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F7">7</xref>
###xml 3179 3181 3179 3181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C36">36</xref>
###xml 3182 3184 3182 3184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C37">37</xref>
###xml 3197 3202 3197 3202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 9 16 <span type="species:ncbi:9606">patient</span>
###xml 1209 1216 <span type="species:ncbi:9606">patient</span>
The COG4 patient is compound heterozygous for a R729W point mutation and a submicroscopical deletion. In heterozygous state, the individual gene defects do not compromise COG function given the absence of clinical features in both parents. The combination, however, results in 20% reduced levels of the mutant COG4 subunit and consequently, the levels of the corresponding lobe A subunits are also significantly reduced, a feature reminiscent of COG mutations (12,14-19). Unexpectedly, a significant drop in COG5, a lobe B subunit, was observed suggesting interaction of COG5 with lobe A (subunits). In support, COG5 was demonstrated in vitro to interact with COG4 (11) as well as with COG1 (27). Nevertheless, the remaining mutant COG4 protein retains its capacity to integrate in an octameric COG complex as demonstrated by glycerol gradient centrifugation. This also implies that the destabilized COG1, which bridges both lobes through its interaction with COG8, is still present in sufficient amounts for complex formation (12,24). Our data therefore suggest the existence of a pool of subunits or subcomplexes from which full complexes can be assembled according to the cellular needs. Hence in the COG4 patient cells, the reduced lobe A levels are apparently sufficient to maintain a basal level of COG complex formation. Indeed, the fact that over 90% of the COG proteins are cytosolic and mostly distributing in the lighter fractions of the gradient suggests that they are predominantly associated in their lobe A or B configuration. On the other hand, when analyzing membrane extracts, most subunits are trailing broadly over almost the complete gradient suggesting an additional association in higher order complexes, likely the full COG complex. The observation that mutant COG8 membrane extracts (in which the lobe A and B bridging is disrupted) lack this trailing indicates that in this case only (partial) subcomplexes are membrane bound. In the light of these data, it is tempting to suggest two possible mechanisms in which the COG complex could tether incoming vesicles. First, lobe A and B might be recruited to the membrane of either the incoming vesicle or the target (Golgi cisternal) membrane. When in close proximity, both lobes can combine to a full complex thereby tethering the transport vesicle to the cisterna. After fusion, the full complex dissociates from the membrane and into subcomplexes (Fig. 7A). This model is in agreement with the proposed working mechanism of the exocyst complex at the cell surface. It has been reported that the Sec3p and Exo70p exocyst subunits localize to the target membrane, whereas the others are recruited to the vesicle and full complex formation assists tethering (34). On the other hand, and in analogy to the TRAPP complex (34), all eight subunits might assemble in the cytosol and be recruited to either the vesicular or target membrane and assist tethering after capture of the vesicle by other proteins, such as p115 for which an interaction with COG2 has been demonstrated (35) (Fig.7B). However, giving the striking similarity in the sequence and structure between subunits of the exocyst and COG complex (36,37, Richardson et al., manuscript in preparation), the first model is favoured here. Whether the recruitment of both lobes, or the full complex occurs directly through lipid interactions or via yet to be identified membrane proteins on the vesicle and/or cisternal membrane remains to be explored.
###end p 34
###begin p 35
###xml 367 368 367 368 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 441 442 441 442 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Hypothetical models on (the regulation of) the action of the COG complex. Retrograde transport organelles as well as target antecedent cisternal membranes are proposed to recruit single lobe A or B subcomplexes (red and blue circles) from cytosolic pools. Tethering of the vesicle to the cisternal membrane occurs by binding of both lobes and full complex formation (A) or by directly binding of the full complex to either of the membranes (B). Recruitment of the COG complex to the membrane may include, as yet unknown, proteins (orange and purple boxes). Also, model B suggests the presence of a long-distance tether (green line) that initially captures the vesicle prior to COG complex recruitment. After tethering, the soluble NSF attachment protein receptor (SNARE) fusion machinery drives the fusion of vesicle and membrane followed by dissociation of the COG complex from the membrane and from each other.
###end p 35
###begin p 36
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C12">12</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C14">14</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C15">15</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C28">28</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C38">38</xref>
###xml 240 245 <span type="species:ncbi:9606">human</span>
The presence of a major cytosolic reserve pool is supported by immunolocalization studies that showed no significant alterations in the Golgi association of the mutant COG4 or other COG subunits. Only in more dramatic cases, such as in the human fibroblasts deficient in COG 1, COG7 or COG8 (12,14,15) but also after knock-down of COG2, COG3 or COG5 (28,38), the steady-state localization of some of the cognate subunits was affected; this is likely due to the abrogation of inter-subunit interactions caused by e.g. the truncation or destabilization of the COG1 and/or COG8 proteins.
###end p 36
###begin title 37
Cellular implications of single COG subunit deficiencies
###end title 37
###begin p 38
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C32">32</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C39">39</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C40">40</xref>
###xml 536 537 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C8">8</xref>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C9">9</xref>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C41">41</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C43">43</xref>
###xml 1118 1120 1118 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C13">13</xref>
###xml 1121 1123 1121 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C44">44</xref>
###xml 1280 1282 1280 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C38">38</xref>
###xml 1356 1358 1356 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C45">45</xref>
###xml 1488 1490 1488 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C46">46</xref>
###xml 1385 1390 <span type="species:ncbi:4932">yeast</span>
###xml 1774 1782 <span type="species:ncbi:9606">patients</span>
At the cellular level, all COG mutations display a significant mild to severe delay in BFA-induced redistribution of Golgi enzymes (as evidenced by mannosidase II) or Golgi matrix proteins (such as GM130) to the ER, ER exit sites or perinuclear vesicular structures (32,39,40). The lack of any effect in BFA wash-out experiments clearly indicates a retrograde transport defect and a putative role for the COG complex in tethering retrograde transport vesicles to the antecedent cisternae as predicted by the cisternal maturation model (8,9,41-43). Any defect in retrograde intra-Golgi trafficking and tethering is likely to affect Golgi morphology due to imbalanced transport of e.g. cargo. Indeed ultrastructural analysis revealed abundant Golgi fragmentation, vesiculation and cisternal vacuolization in all mutant COG fibroblasts largely correlating with the severity of the mutations and the observed delays in BFA-induced redistributions. In agreement, overall Golgi fragmentation, often associated with vacuolated cisternae, was observed for the ldlB and ldlC mutant CHO cells, deficient in either COG1 or COG2 (13,44). Downregulation of COG3 resulted in the formation of Golgi mini-stacks and an extensive accumulation of small vesicles distinct from COPI-coated vesicles (38), whereas knockdown of COG5 in CHO cells showed dilated Golgi cisternae (45). Finally, mutants of the yeast COG4 homologue, Sgf1, showed an accumulation of membranes, most likely Golgi transport vesicles (46). These findings underscore our findings that a deficiency in a given COG subunit substantially affects Golgi integrity. On the other hand, we also observed unexpected and novel alterations of the Golgi morphology including the presence of undulated cisternae (e.g. in COG7 and COG8 patients' cells). This points to a destabilization in the connection of the Golgi cisternae with the underlying cytoskeleton and suggests, besides a role in retrograde transport, an additional function of the COG complex (or one or more of its subunits) in tethering Golgi membranes to microtubules.
###end p 38
###begin p 39
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 648 649 648 649 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 655 656 655 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1065 1067 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C12">12</xref>
###xml 1068 1070 1062 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C15">15</xref>
###xml 424 432 <span type="species:ncbi:9606">patients</span>
###xml 684 692 <span type="species:ncbi:9606">patients</span>
###xml 854 861 <span type="species:ncbi:9606">patient</span>
###xml 967 974 <span type="species:ncbi:9606">patient</span>
Given their Golgi localization, the observed defects in Golgi transport and morphology, COG subunit mutations are prone to affect the Golgi glycosylation processes. Still, this is the first study in its kind to analytically compare such Golgi glycosylation defects between the mutant COG subunits. Mass spectroscopical analysis of total serum N-glycans revealed an overall decrease in sialylation and galactosylation in all patients. Strong differences in the relative amounts of oligosaccharides and the presence of unexpected oligosaccharide structures were observed according to the affected COG subunits. Most striking was the presence of a Man5GlcNAc2 structure in COG1 and COG7 patients, suggesting an abnormal localization and/or activity of GlcNAcT1. In previous studies also a destabilization of ManII and beta-1,4-GalT1 was noticed in the COG1 patient, likely explaining the observed demannosylation and galactosylation defects. On the other hand, the COG8 patient only showed a destabilization of beta-1,4-GalT1 resulting in a decreased galactosylation (12,15). We can, however, not exclude that all observed glycosylation defects are caused by mislocalization of the classical glycosylation enzymes. Indeed, proper glycosylation is also crucially dependent on nucleotide-sugar transporters and mislocalization or degradation of such transporters would affect Golgi glycosylation.
###end p 39
###begin p 40
###xml 665 666 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP262F3">3</xref>
###xml 1338 1340 1338 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C10">10</xref>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
###xml 741 748 <span type="species:ncbi:9606">patient</span>
###xml 1856 1864 <span type="species:ncbi:9606">patients</span>
There is a strong correlation between the severities of the trafficking and glycosylation abnormalities in all patients' cell lines. Hence it is likely that the deficiency in tethering of intra-Golgi retrograde vesicles impairs recycling of the responsible enzymes and/or nucleotide-sugar transporters back to their correct cisternae. Given the defects in COG function and their, mostly dramatic, effects on intra-Golgi transport and Golgi integrity, one wonders how such cells still manage to generate a vast percentage of normal oligosaccharide chains. After all, even the clinically and cellularly most severe COG7 mutation succeeds partially in this task (Fig. 3A and B). On the other hand, clinically less severe cases such as the COG1 patient have more pronounced glycosylation defects compared with others. All this suggests a high degree of plasticity of the Golgi apparatus to maintain minimal function even when structurally affected. Given the heavily disorganized or even residual appearance of Golgi complexes in the different COG mutants and mostly the lack of recognizable cisternal organization, this plasticity is difficult to explain only on the basis of the 'cisternal maturation' model. Keeping a minimal fidelity in glycosylation could, however, be explained by the Golgi apparatus being a two-phase membrane system (10). In this model, enzymes and transmembrane cargo not only rapidly partition between two lipid phases but also exchange fast among cisternae. This rapid cargo mixing upon Golgi entry and the absence of a defined transit time as predicted by this model increases the likelihood of cargo to encounter the set of enzymes required for complex glycosylation. One could imagine that even in severely disorganized Golgi complexes such a system could support minimal glycosylation processes as observed in the different COG patients. Although speculative for the moment, cells harbouring mutant COG subunits have the potency to provide the litmus test for this provocative model on intra-Golgi transport.
###end p 40
###begin title 41
Concluding remarks
###end title 41
###begin p 42
###xml 95 103 <span type="species:ncbi:9606">patients</span>
In conclusion, we experimentally demonstrated here that 'natural COG mutants', found in CDG-II patients, allow for a better understanding of the role of the full COG complex and of the individual subunits and subcomplexes in tethering Golgi vesicles. Moreover, we also highlighted the important contribution of characterizing clinical mutations in the molecular and cell biological understanding of Golgi dynamics and its associated functions permitting to propose novel mechanisms or testing existing models. The predominance of COG mutations as a possible cause of CDG-II also predicts that within the growing pool of unresolved cases, likely more candidate genes will be found whose products function in intra-Golgi transport regulation.
###end p 42
###begin title 43
MATERIAL AND METHODS
###end title 43
###begin title 44
Cell culture and transfections
###end title 44
###begin p 45
###xml 237 238 231 232 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 35 43 <span type="species:ncbi:9606">patients</span>
###xml 155 161 <span type="species:ncbi:9913">Bovine</span>
Primary fibroblasts, obtained from patients and controls, and HeLa cells were cultured in DMEM/F12 (Life Technologies, Paisley, UK), supplemented with 10% Bovine Growth Serum (HyClone, Logan, UT, USA) and were kept at 37degreesC in 5% CO2.
###end p 45
###begin title 46
Antibodies
###end title 46
###begin p 47
###xml 77 83 <span type="species:ncbi:9986">rabbit</span>
Antibodies against the COG1-8 subunits were affinity purified or crude serum rabbit polyclonal antibodies. Dilutions ranged from 1 in 500 to 1 in 2000 for western blot and from 1 in 50 to 1 in 200 for confocal laser scanning microscopy imaging. Anti-COG3 pab, anti-mannosidase II pab and anti-beta-1,4-GalT1 mab were gifts from, respectively, V. Lupashin (University of Arkansas for Medical Sciences, Little Rock, AR, USA), K. Moremen (University of Georgia, Athens) and E. Berger (University of Zurich, Zurich). Anti-GM130 mab was purchased from BD Biosciences (Franklin Lakes, NJ, USA).
###end p 47
###begin title 48
Plasmids
###end title 48
###begin p 49
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COG4</italic>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C47">47</xref>
COG4 cDNA (NM_015386) was cloned into the pMSCV retroviral vector (Clontech Laboratories, Mountain View, CA 94043, USA), engineered with a polylinker site, as described before (47). For the production of retrovirus, we used the packaging pVPACK-Ampho vector (Stratagene, La Jolla, CA 92037, USA).
###end p 49
###begin title 50
###xml 31 32 31 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
Mass spectrometric analysis of N-linked glycans released from total plasma proteins
###end title 50
###begin p 51
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 214 219 214 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C48">48</xref>
###xml 279 280 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 349 350 349 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 437 442 437 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C48">48</xref>
###xml 507 515 <span type="species:ncbi:9606">patients</span>
Analysis of N-linked glycans on plasma glycoproteins was carried out by surface-enhanced laser desorption ionization time-of-flight mass spectrometry (Ciphergen, Fremont, CA, USA) essentially as described by Mills et al. (48). for MALDI-TOF mass spectrometry. Analysis of acidic N-linked glycans was performed in negative linear ion mode. The total N-linked glycans from plasma proteins were released enzymatically as described by Mills et al. (48). The reference samples were anonymous plasma samples from patients without CDG or a lysosomal storage disease.
###end p 51
###begin title 52
Preparation of cytosol and membrane fractions
###end title 52
###begin p 53
###xml 118 119 118 119 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 363 364 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 470 471 464 465 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 518 519 512 513 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 643 644 631 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 790 791 772 773 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 798 799 780 781 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 21 28 <span type="species:ncbi:9606">patient</span>
Cells of control and patient were cultured in 75 cm dishes up to 90% confluency and harvested, on ice, in 1 ml of 20 mm HEPES-KOH buffer pH 7.4, supplemented with a protease inhibitor cocktail. Cells were subsequently homogenized using a ball-bearing type homogenizer. Separation of membrane and cytosol was obtained upon ultracentrifugation during 1 h at 100 000g at 4degreesC. After removal and storage of the cytosolic fractions, the pellet was dissolved in 1 ml 20 mm HEPES-KOH buffer pH 7.4 supplemented with 0.1 m NaCl and 1% CHAPS. After 1 h incubation at 4degreesC the insoluble material was pelleted upon ultracentrifugation at 55 000g during 15 min at 4degreesC. The membrane-containing supernatant fractions were removed and stored. The obtained samples were concentrated by CHCl3/MeOH/H2O (3/2/1) precipitation and subsequently loaded onto a 4-12% Bis-Tris SDS-PAGE pre-casted electrophoresis gel (Invitrogen, Carlsbad, CA, USA) and further processed as described in the .
###end p 53
###begin title 54
Glycerol gradient centrifugation
###end title 54
###begin p 55
###xml 243 244 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 431 432 431 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 439 440 439 440 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Preparation of the cytosolic and membrane fractions was identical to the protocol above. After collection, the samples were loaded onto a 12 ml 10-30% glycerol (w/v) gradient. The gradients were centrifugated in a Beckman SW40 rotor at 120 000g during 15 h, with slow acceleration and deceleration. Fractions of 1 ml were collected via a hole punched in the bottom of the tubes. Concentration of the samples was also done by a CHCl3/MeOH/H2O (3/2/1) precipitation, followed by loading of the resulting fractions onto a 4-12% Bis-Tris SDS-PAGE pre-casted electrophoresis gel and further processed as described in the .
###end p 55
###begin title 56
ER-Golgi trafficking assay
###end title 56
###begin p 57
Cells were seeded onto glass coverslips in a six-well plate and allowed to grow until 75-90% confluency during 48 h. To assay the retrograde Golgi-to-ER trafficking BFA, purchased from Sigma (St Louis, MO, USA), was diluted up to 5 microg/ml in normal growth medium and this solution was pre-warmed at 37degreesC, before adding to the cells. Two millilitre of medium containing the drug was added per well and the cells were replaced in the incubator as soon as possible. Immediately after the end of the treatment, the plates were put on ice, the medium was taken off and 1 ml of 4% paraformaldehyde was added per well. After a 30 min fixation the coverslips were further stained for GM130 and mannosidase II, as described in the .
###end p 57
###begin p 58
To assay the anterograde ER-to-Golgi trafficking and the reformation of the Golgi from the ER, BFA was diluted up to 0.25 microg/ml in normal growth medium. After pre-warming the solution to 37degreesC, 2 ml was added per well and the cells were replaced in the incubator for 1 h. Afterwards, the coverslips were extensively washed in PBS and placed in new wells, containing fresh, BFA-free, medium. The plates were again placed in the incubator, for 90 min, after which the cells were put on ice, washed and fixed with paraformaldehyde. Again this treatment was followed by immunofluorescence staining for GM130 and mannosidase II, as described in the .
###end p 58
###begin title 59
Transmission electron microscopy
###end title 59
###begin p 60
###xml 35 36 35 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 133 134 133 134 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP262C49">49</xref>
For TEM cells were grown in a 25 cm2 flask and, upon reaching 95% confluency, fixed for 30 min at RT with 2% paraformaldehyde in 0.1 m phosphate buffer pH 7.4. After removal of the fixative cells were kept in 4% paraformaldehyde until processing for EPON embedding, as described previously (49) and analyzed after ultrathin sectioning.
###end p 60
###begin title 61
Production of retroviral particles
###end title 61
###begin p 62
Cultured 293T cells are splitted 1 over 20 before reaching 70% confluency and plated in a 15 cm dish. Upon reaching 90% of confluency the cells are transfected with the pMSCV vector and the pVPACK-Ampho plasmid (in total 20 microg) in serum-free DMEM/F12 medium (Life Technologies, Paisley, UK) and using Fugene-6 (Roche Applied Science, Indianapolis, IN, USA). The medium is replaced 24 h after transfection and 24 h later the first retroviral-containing supernatant is harvested, using a blunt-end needle and a 0.45 microm filter. In total, four harvests were obtained, with an alternating time difference of 6 and 12 h between two harvests. Obtained samples were instantly frozen in liquid nitrogen and stored at -80degreesC.
###end p 62
###begin title 63
Transduction of fibroblasts
###end title 63
###begin p 64
One day in advance cells are splitted into a six-well plate at 150 000 cells per well, in order to have a 50-70% confluency the day after. The medium is removed and 1 ml medium containing 16 microg polybrene (Sigma) and 1 ml of viral supernatant are added. After 24 h, the selection using puromycin (Sigma) is started in order to obtain a stable cell line.
###end p 64
###begin title 65
SUPPLEMENTARY MATERIAL
###end title 65
###begin p 66

###end p 66
###begin title 67
[Supplementary Data]
###end title 67
###begin title 68
FUNDING
###end title 68
###begin p 69
###xml 30 118 30 118 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8216;Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie Vlaanderen&#8217;</funding-source>
###xml 151 158 151 158 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SB53523</award-id>
###xml 171 221 171 221 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8216;Fonds voor Wetenschappelijk Onderzoek Vlaanderen&#8217;</funding-source>
###xml 256 265 256 265 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G.0504.06</award-id>
###xml 290 299 290 299 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G.0553.08</award-id>
###xml 478 523 478 523 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sixth Framework program of the European Union</funding-source>
###xml 557 568 557 568 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2005-512131</award-id>
This work was supported by an 'Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie Vlaanderen' (IWT) scholarship [grant number SB53523] to E.R.; a 'Fonds voor Wetenschappelijk Onderzoek Vlaanderen' (FWO) grant to W.A. [grant number G.0504.06] and G.M. [grant number G.0553.08]; a Marie Curie European Reintegration Grant to F.F.; the 'Vlaams Instituut voor Biotechnologie' (VIB) (to W.A.); the 'Katholieke Universiteit Leuven' (to W.A. and G.M.) and the Sixth Framework program of the European Union [Euroglycanet grant number: LSHM-2005-512131] (to G.M.). Funding to pay the Open Access publication Charges for this article was provided by a 'Fonds voor Wetenschappelijk Onderzoek Vlaanderen' (FWO) grant to W.A. [Grant number G.0504.06].
###end p 69
###begin title 70
ACKNOWLEDGEMENTS
###end title 70
###begin p 71
###xml 432 437 <span type="species:ncbi:9606">Human</span>
We gratefully thank B. Richardson, V. Lupashin and F. Hughson for the communication of results prior to publication. This work was greatly supported through discussions with and help of Dr J. Jaeken, Dr H. Carchon, Dr R. Zeevaert and S. van Aerschot (Universitary Hospital of Leuven), Dr L. Vilarinho (Medical Genetics Institute, Porto), Dr J. Vermeesch, Dr T. Voet, Dr G. Froyen, L. Keldermans, W. Vleugels, R. Thoelen (Center for Human Genetics, Leuven) and D. Xanthakis (University Medical Center Utrecht). We are grateful to Dr K. Moremen, Dr E.G. Berger and Dr V. Lupashin for kindly providing us with antibodies.
###end p 71
###begin p 72
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement.</italic>
Conflict of Interest statement. None declared.
###end p 72
###begin title 73
REFERENCES
###end title 73
###begin article-title 74
Cell cycle maintenance and biogenesis of the Golgi complex
###end article-title 74
###begin article-title 75
###xml 36 37 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
Unraveling the mechanism of protein N-glycosylation
###end article-title 75
###begin article-title 76
The organizing potential of sphingolipids in intracellular membrane transport
###end article-title 76
###begin article-title 77
Compartmental organization of the Golgi stack
###end article-title 77
###begin article-title 78
Intercompartmental transport in the Golgi complex is a dissociative process: facile transfer of membrane protein between two Golgi populations
###end article-title 78
###begin article-title 79
Cholesterol and the Golgi apparatus
###end article-title 79
###begin article-title 80
Retention and retrieval in the endoplasmic reticulum and the Golgi apparatus
###end article-title 80
###begin article-title 81
A cisternal maturation mechanism can explain the asymmetry of the Golgi stack
###end article-title 81
###begin article-title 82
Subcompartmentalizing the Golgi apparatus
###end article-title 82
###begin article-title 83
Transport through the Golgi apparatus by rapid partitioning within a two-phase membrane system
###end article-title 83
###begin article-title 84
Subunit architecture of the conserved oligomeric Golgi complex
###end article-title 84
###begin article-title 85
A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation
###end article-title 85
###begin article-title 86
Characterization of a mammalian Golgi-localized protein complex, COG, that is required for normal Golgi morphology and function
###end article-title 86
###begin article-title 87
Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder
###end article-title 87
###begin article-title 88
Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II
###end article-title 88
###begin article-title 89
COG8 deficiency causes new congenital disorder of glycosylation type IIh
###end article-title 89
###begin article-title 90
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COG7</italic>
A common mutation in the COG7 gene with a consistent phenotype including microcephaly, adducted thumbs, growth retardation, VSD and episodes of hyperthermia
###end article-title 90
###begin article-title 91
###xml 69 76 <span type="species:ncbi:9606">patient</span>
Molecular and clinical characterization of a Moroccan Cog7 deficient patient
###end article-title 91
###begin article-title 92
Cerebrocostomandibular-like syndrome and a mutation in the conserved oligomeric Golgi complex, subunit 1
###end article-title 92
###begin article-title 93
Congenital disorders of glycosylation: a review
###end article-title 93
###begin article-title 94
Komrower lecture. Congenital disorders of glycosylation (CDG): it's all in it!
###end article-title 94
###begin article-title 95
###xml 24 25 24 25 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 18 23 <span type="species:ncbi:9606">human</span>
Identification of human l-fucose kinase amino acid sequence
###end article-title 95
###begin article-title 96
###xml 100 108 100 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Purification and characterization of a novel 13 S hetero-oligomeric protein complex that stimulates in vitro Golgi transport
###end article-title 96
###begin article-title 97
Expression cloning of LDLB, a gene essential for normal Golgi function and assembly of the ldlCp complex
###end article-title 97
###begin article-title 98
High-copy suppressor analysis reveals a physical interaction between Sec34p and Sec35p, a protein implicated in vesicle docking
###end article-title 98
###begin article-title 99
###xml 60 65 <span type="species:ncbi:4932">yeast</span>
Identification of Sec36p, Sec37p, and Sec38p: components of yeast complex that contains Sec34p and Sec35p
###end article-title 99
###begin article-title 100
###xml 54 59 <span type="species:ncbi:4932">yeast</span>
Cog1p plays a central role in the organization of the yeast conserved oligomeric Golgi complex
###end article-title 100
###begin article-title 101
LDLC encodes a brefeldin A-sensitive, peripheral Golgi protein required for normal Golgi function
###end article-title 101
###begin article-title 102
###xml 28 29 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId
###end article-title 102
###begin article-title 103
COG complex-mediated recycling of Golgi glycosyltransferases is essential for normal protein glycosylation
###end article-title 103
###begin article-title 104
Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER
###end article-title 104
###begin article-title 105
Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway
###end article-title 105
###begin article-title 106
Brefeldin A: the advantage of being uncompetitive
###end article-title 106
###begin article-title 107
Diversity in structure and function of tethering complexes: evidence for different mechanisms in vesicular transport regulation
###end article-title 107
###begin article-title 108
The interaction of two tethering factors, p115 and COG complex, is required for Golgi integrity
###end article-title 108
###begin article-title 109
Structural analysis of conserved oligomeric Golgi complex subunit 2
###end article-title 109
###begin article-title 110
The Sec34/35 Golgi transport complex is related to the exocyst, defining a family of complexes involved in multiple steps of membrane traffic
###end article-title 110
###begin article-title 111
Cog3p depletion blocks vesicle-mediated Golgi retrograde trafficking in HeLa cells
###end article-title 111
###begin article-title 112
Matrix proteins can generate the higher order architecture of the Golgi apparatus
###end article-title 112
###begin article-title 113
Cis-Golgi matrix proteins move directly to endoplasmic reticulum exit sites by association with tubules
###end article-title 113
###begin article-title 114
Procollagen traverses the Golgi stack without leaving the lumen of cisternae: evidence for cisternal maturation
###end article-title 114
###begin article-title 115
Small cargo proteins and large aggregates can traverse the Golgi by a common mechanism without leaving the lumen of cisternae
###end article-title 115
###begin article-title 116
Peri-Golgi vesicles contain retrograde but not anterograde proteins consistent with the cisternal progression model of intra-Golgi transport
###end article-title 116
###begin article-title 117
IntraGolgi distribution of the conserved oligomeric Golgi (COG) complex
###end article-title 117
###begin article-title 118
Genetic analysis of the subunit organization and function of the COG complex: studies of Cog5 and Cog7 deficient mammalian cells
###end article-title 118
###begin article-title 119
Sgf1p, a new component of the Sec34p/Sec35p complex
###end article-title 119
###begin article-title 120
Presenilin-1 maintains a nine-transmembrane topology throughout the secretory pathway
###end article-title 120
###begin article-title 121
Mass spectrometric analysis of glycans in elucidating the pathogenesis of CDG type IIx
###end article-title 121
###begin article-title 122
###xml 91 98 91 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
The role of the tethering proteins p115 and GM130 in transport through the Golgi apparatus in vivo
###end article-title 122

